Level Four Financial’s Allena Pharmaceuticals ALNA Stock Holding History

Level Four Financial’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$36K	Buy	40,000 +20,000	+100%	+$19.6K	0.02%	292
2021 Q2	$26K	Hold	20,000	–	–	0.01%	314
2021 Q1	$28K	Buy	+20,000	New	+$33.3K	0.01%	281

Other funds holding ALNA

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Level Four Financial's ALNA Position: Q3 2021 in Review

Level Four Financial increased its Allena Pharmaceuticals (ALNA) stake by 100% in Q3 2021, buying an estimated $19.6K and bringing the position to 40,000 shares worth $36K. The position accounts for 0.02% of the portfolio, ranked #292.

Level Four Financial first reported a position in ALNA in Q1 2021 and has held it in 3 quarters since. 36 funds tracked by Wall St. Rank hold ALNA as of Q3 2021.

Level Four Financial held 40,000 shares of Allena Pharmaceuticals worth $36K as of Q3 2021.
Level Four Financial bought 20,000 Allena Pharmaceuticals shares in Q3 2021, an estimated $19.6K.
Allena Pharmaceuticals made up 0.02% of Level Four Financial's portfolio in Q3 2021, its #292 holding.
Level Four Financial first reported a position in Allena Pharmaceuticals in Q1 2021 and has held it in 3 quarters since.
36 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2021.

Based on Level Four Financial's 13F filing for Q3 2021, filed 12 Oct 2021.